Outpatient continuous-infusion benzylpenicillin combined with either gentamicin or ceftriaxone for enterococcal
Simon Briggs1, Matthew Broom1, Eamon Duffy1
1Infectious Disease Unit, Auckland City Hospital, Auckland, New Zealand.
Background:
Treatment regimens requiring multiple daily dosing for enterococcal endocarditis are challenging to deliver in the outpatient setting. Continuous-infusion benzylpenicillin via a 24 h elastomeric infusor, combined with either once-daily gentamicin or ceftriaxone, requires only one nursing encounter daily and is commonly used in New Zealand.
Objectives:
To assess the therapeutic success and adverse antibiotic effects of these regimens.
Methods:
A retrospective observational case series from multiple hospitals of patients aged 15 years or over with enterococcal endocarditis diagnosed between July 2013 and June 2019 who received at least 14 days of outpatient continuous-infusion benzylpenicillin combined with either gentamicin or ceftriaxone for synergy.
Results:
Forty-three episodes of enterococcal endocarditis in 41 patients met inclusion criteria. The primary synergy antibiotic was gentamicin in 20 episodes and ceftriaxone in 23 episodes. For the 41 initial treatment courses, 31 (76%) patients were cured, 3 (7%) patients developed relapsed endocarditis during or following antibiotic treatment and 7 (17%) patients continued with long-term suppressive oral amoxicillin following IV antibiotic treatment. There was no difference in the relapse rate between the two groups (P = 0.59). Seven (35%) adverse antibiotic effects were documented in the gentamicin group and none in the ceftriaxone group (P < 0.01). Two deaths (5%) occurred within the 6 month follow-up period.
Conclusions:
Outpatient treatment of enterococcal endocarditis with continuous-infusion benzylpenicillin combined with either once-daily gentamicin or ceftriaxone following a period of inpatient treatment is usually effective. A significantly higher rate of adverse effects was seen with gentamicin, favouring ceftriaxone as the initial synergy antibiotic.
Insights
Continuous-infusion benzylpenicillin with daily gentamicin or ceftriaxone is effective for outpatient enterococcal endocarditis. Ceftriaxone demonstrated fewer adverse antibiotic effects compared to gentamicin.
Area of Science:
- Infectious Diseases
- Pharmacology
- Cardiology
Background:
- Enterococcal endocarditis treatment often requires complex dosing regimens challenging for outpatient settings.
- Continuous-infusion benzylpenicillin with once-daily synergistic antibiotics simplifies outpatient care.
- Commonly utilized regimens in New Zealand involve benzylpenicillin with either gentamicin or ceftriaxone.
Purpose of the Study:
- To evaluate the therapeutic success of outpatient enterococcal endocarditis treatment.
- To assess the incidence and types of adverse antibiotic effects associated with these regimens.
- To compare the efficacy and safety of gentamicin versus ceftriaxone as synergistic agents.
Main Methods:
- Retrospective observational case series of patients aged 15 years and older.
- Inclusion criteria: diagnosis of enterococcal endocarditis and at least 14 days of outpatient continuous-infusion benzylpenicillin with gentamicin or ceftriaxone.
- Data collected on treatment outcomes, relapse rates, and adverse antibiotic effects.
Main Results:
- Forty-three episodes of enterococcal endocarditis were analyzed.
- Overall cure rate was 76%, with 7% experiencing relapse and 17% requiring suppressive oral therapy.
- Significantly more adverse effects were observed with gentamicin (35%) compared to ceftriaxone (0%) (P < 0.01).
Conclusions:
- Outpatient continuous-infusion benzylpenicillin combined with once-daily gentamicin or ceftriaxone is generally effective for enterococcal endocarditis.
- Ceftriaxone is favored over gentamicin as the initial synergistic antibiotic due to a significantly lower rate of adverse effects.
- These findings support the use of ceftriaxone in simplified outpatient treatment regimens.
Related Concept Videos
Endocarditis IV: Nursing Management
Endocarditis III: Medical Management
Endocarditis I: Introduction
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Acute Pyelonephritis II: Diagnostic Studies and Management
Endocarditis II: Clinical Features of Infective Endocarditis


